Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, and commercializes genetic medicines for patients with rare diseases in the United States. It commercializes ...
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex ...
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel ...
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology ...
Dealbreaker on MSN2d
Ascentage Has First U.S. Biotech IPO of 2025, Raising $126M to Bring Its Cancer Meds to the WorldAscentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...
China-based veterinary vaccine manufacturer—Zhengye Biotechnology (ZYBT ... under the ticker symbol "ZYBT." The offering is expected to close on or about January 8, 2025. Gross proceeds are ...
Ventana Biotech, Inc. ("Ventana" or the "Company") today announced that it has changed its name to Ventana Global, Inc. (OTC Pink: VNTAD) from Ventana ...
Jilin, China, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited ... 2025 under the ticker symbol "ZYBT." The Offering is expected to close on or about January 8, 2025 ...
Photos Martin Luther King Jr ...
Video Back Videos home Signature collection Essentials collection Artificial Intelligence ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback